Wockhardt shares pause massive 36% rally in 5 sessions; slip 7%. What’s behind the selloff?Wockhardt shares dropped after a recent surge, as investors took profits. This followed the US FDA approval of ZAYNICH, an antibiotic for u...
02 Jun, 2026, 11.10 AM IST
Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
02 Jun, 2026, 05.48 AM IST
Delhi HC allows Intas to sell cancer drug Bevatas, sets aside order favouring Sun PharmaThe Delhi High Court division bench has ruled in favor of Intas Pharmaceuticals, allowing the company to introduce its anti-cancer medicati...
02 Jun, 2026, 12.05 AM IST
If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
02 Jun, 2026, 12.01 AM IST
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
29 May, 2026, 11.05 AM IST
Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...
19 May, 2026, 10.34 AM IST
Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...
13 May, 2026, 01.17 PM IST
Ahead of Market: 10 things that will decide stock market action on WednesdayIndian markets closed lower amid selling in financial, consumer and realty stocks, with Nifty and Sensex declining. Technical indicators si...
05 May, 2026, 09.31 PM IST
Wockhardt shares jump 9% after strong Q4 turnaround, robust FY26 growthWockhardt shares saw a significant jump on Tuesday. The pharmaceutical company reported a strong turnaround in its March quarter performanc...
05 May, 2026, 10.29 AM IST
Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulinWockhardt Ltd has decided to shut down its loss-making US generics business to channel its energy and funds into developing new antibiotics...
11 Jul, 2025, 05.15 PM IST
- Wockhardt hits lifetime high, up 170% in 2012
Wockhardt Ltd surged over 6% in trade to hits its lifetime high of Rs 773.00 on Wednesday on the back of steady performance and valuations ...
23 May, 2012, 01.47 PM IST
- Wockhardt’s earnings are likely to continue growing at 25%
Investors of Wockhardt Pharmaceutical should not fret much about the reported loss in the quarter to March given the fundamentals of the co...
23 May, 2012, 09.09 AM IST
- Wockhardt, RBS settle case mutually
Pharma major Wockhardt Pharmaceutical and its lender, Royal Bank of Scotland, on Thursday agreed to mutually settle their case relating to ...
16 Jun, 2011, 11.00 PM IST
- Fire damages Wockhardt's unit at Ankleshwar
A fire at pharmaceutical major Wockhardt’s Rs 300-crore Ankleshwar facility damaged one of its six manufacturing plants.
30 Apr, 2010, 01.26 AM IST
- Wockhardt acquires US-based Morton Grove
Pharmaceutical major Wockhardt Ltd has acquired Morton Grove Pharmaceuticals, a liquid generic and specialty dermatology company in the US ...
24 Oct, 2007, 11.46 AM IST
- Wockhardt buys French co for Rs 1,090 cr
Wockhardt has acquired Negma Laboratories in cash - a deal that would give it access to the European mkt.
03 May, 2007, 01.00 PM IST
- Wockhardt signs MoU for pharma SEZ in M’rashtra
Pharmaceutical and biotechnology major Wockhardt signed a memorandum of understanding (MoU) with Maharashtra Industrial Development Corpora...
18 Sep, 2006, 02.55 AM IST